A personalized alert tool improve use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for ...

Patients who had been taking an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) for preexisting hypertension had lower in-hospital mortality but stayed longer in ...

—Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help. When it ...

Toronto, ON - A new meta-analysis comparing angiotensin receptor blockers (ARBs) to placebo or ACE inhibitors in heart failure patients "cannot claim that ARBs are superior" to ACE inhibitors in ...

In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...

(UPDATED) Another observational study, in the form of a large analysis of US patients with hypertension, indicates that ACE inhibitors and ARBs are not associated with an increased risk of COVID-19 ...

Among four classes of blood pressure medication, angiotensin receptor blockers (ARBs) had the highest medication persistence, meaning patients taking the drugs were most likely to stay on them. This ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...

Close-up of senior black woman sorting weekly medication. Member of a black middle class America family. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the ...

Antihypertensive regimens that include a mineralocorticoid receptor antagonist carry the highest risk for hyperkalemia. Among the drug combinations that may increase serum potassium in patients with ...